Sikiric et al., 2018), along with the evidence that pentadecapeptide BPC 157 may prevent and/or attenuate or eliminate, thus, counteract both developing and already formed both arterial thrombosis (Hrelec et al., 2009
The most commonly described approach for body composition and sleep optimisation involves a single evening injection timed 3060 minutes before sleep in a fasted state
Meanwhile, evidence is mounting of the wider therapeutic benefits of GLP-1 drugs, with clinical trials ongoing for metabolic liver disease, cardiovascular diseases, chronic kidney disease, and neurological disorders, among others
Try out our Product
This science-first ingredient underpins Cellular Prime's evidence-based formulations
Many users report optimal results at this level without needing to progress further